ChatYou are Viewing our Top Doctor

ChatChat on WhatsApp

About Dr. Mallikarjun Kalashetty

Dr. Mallikarjun Kalashetty is a leading hematologist in India, recognized for his depth in treating malignant blood disorders (leukemia, lymphoma, myeloma), benign hematologic conditions (aplastic anemia, thalassemia, hemophilia), and conducting advanced bone marrow and stem cell transplants.

OPD Schedule Of Dr. Mallikarjun Kalashetty

Consultation Fees Rs. 850 /-
Manipal Hospital (Old Airport Road) Bangalore
MON 12:00 PM - 03:00 PM
TUE 12:00 PM - 03:00 PM
WED 12:00 PM - 03:00 PM
THU 12:00 PM - 03:00 PM
FRI 12:00 PM - 03:00 PM
SAT 12:00 PM - 03:00 PM
ChatWhatsApp

  • MBBS – Jawaharlal Nehru Medical College, Belgaum (2002) 
  • MD in General Medicine – Same institute (2006)
  • DM in Clinical Haematology – Seth G.S. Medical College & KEM Hospital, Mumbai (2012), Gold Medalist 
  • Fellowship in Bone Marrow Transplantation – Vancouver General Hospital, Canada (one year)

 

Major Conditions Treated:

  • Acute and chronic leukemias, Hodgkin’s and Non‑Hodgkin’s lymphomas, multiple myeloma
  • Aplastic anemia, thalassemia, sickle cell anemia, hemophilia, ITP, thrombocytopenia, thrombotic disorders
  • Blood and marrow transplantation for both benign and malignant diseases 

 

Advanced Procedures & Services:

  • Autologous & allogeneic BMT
  • Stem cell transplantation
  • Comprehensive hematologic diagnostics and treatment
  • Management of complex hematologic conditions in ICU, pregnancy, and medical comorbidities

Current Role:
Head of Department & Consultant – Hematology, Haemato‑Oncology, BMT, Manipal Hospital, Old Airport Road, Bengaluru 

 

Past Role

Consultant Clinical Hematology and Incharge Bone Marrow Transplant Program at M S Ramaiah Curie Centre of Oncology - 2013 - 2015 

 

Key Career Highlights:

  • Founded the bone marrow transplant and clinical hematology service at HCG MSR Cancer Centre, MS Ramaiah Medical College, Bengaluru 
  • Extensive experience in transplant protocols gained during his fellowship at Vancouver General Hospital, Canada

  • Gold Medal in DM Clinical Haematology – Seth G. S. Medical College & KEM Hospital, Mumbai
  • Numerous contributions and publications in peer‑reviewed hematology and transplant research

Dr. Kalashetty has authored and co‑authored clinical studies on topics like:

  1. Renal crystal‑storing histiocytosis successfully treated with a bortezomib‑based regimen
  2. Effect of age, comorbidity, and remission status on outcome of COVID‑19 in patients with hematological malignancies



“Dr. Kalashetty’s calm demeanor and strong medical expertise make patients feel confident and well cared for.” 

“He listens patiently, answers all questions thoroughly, and works seamlessly with his team to ensure quality care”

 “A skilled doctor and compassionate person, Dr. Kalashetty treats patients with empathy and clinical excellence”

Dr. Mallikarjun Kalashetty hematologist, prioritizes a multidisciplinary, evidence-based approach, blending global clinical best practices with compassionate patient-centric care. He supports thorough counseling, rational prescribing, and coordinated care plans that involve family support systems.

 

Treatment Type

Cost Range Estimates (INR)

Cost Range Estimates (USD)

Chemotherapy (per session)

20,000 - 45,000

232 - 523

Radiation Therapy (total)

1,50,000 - 4,00,000

1,743 - 4.648

Immunotherapy (per session)

2,00,000 - 5,00,000

2,324 - 5,810

Bone Marrow Transplant (Autologous)

12,00,000 - 18,00,000

13,944 - 20915

  • Language Support
  • Visa & Travel Assistance: Cancer Rounds provides support for visa letters, travel plans, and hospital accommodations.
  • Pre-treatment Virtual Consultations: Patients can consult Dr. Kalashetty online via Cancer Rounds before arrival to discuss diagnosis, treatment plans, and timelines

Frequently Asked Questions

You can book an appointment through Cancer Rounds.

Yes. Virtual consultations for Dr Mallikarjun Kalashetty hematologist are available through Cancer Rounds.

Bring previous blood counts, bone marrow biopsy results, genetic/molecular testing reports, transfusion history, and any relevant imaging or medical notes.

Yes, Cancer Rounds website offers assistance with scheduling, language support, visas, and virtual consultations.

Dr. Mallikarjun Kalashetty is a leading hematologist in India and treats leukemia, lymphoma, myeloma, hemophilia, thalassemia, aplastic anemia, sickle cell disease, ITP, and other complex blood and marrow conditions, including performing BMT.

Our Impact

CancerRounds is making quality cancer care accessible to more people every day.

Send your reports
700+ Oncology Specialists
Send your reports
75+ Partner Hospitals
Send your reports
10000+ Patients Served
Send your reports
98% Patient Satisfaction

Why Choose India for Cancer Treatment?

World-Class Care

World-Class Care

Skilled oncologists provide top-tier medical services

Affordable Treatment

Affordable Treatment

Costs are significantly lower than in Western countries.

Comprehensive Packages

Comprehensive Packages

Hospitals offer all-inclusive plans covering surgery, stay, and aftercare.

Easy Accessibility

Easy Accessibility

Well-connected airports and international flight routes.

Proven Success

Proven Success

High patient satisfaction and positive treatment outcomes

    Get FREE Evaluation

    Treatment plan and quote within 2 days

    FREE, No-Obligation Expert Evaluation

    👥 Trusted by Over 10,000 Patients Worldwide

    🤝 Expert Handholding at Every Step

    “I am now back in Kenya, full of hope and healing — forever grateful for the support I received. Thank you to the amazing team.”

    Belinda, Brain Tumour, Kenya ⭐⭐⭐⭐⭐

    “The expert team made all the difference in my treatment journey. The team at Cancer Rounds stood by me throughout my treatment.”

    Maria, Breast Cancer, USA ⭐⭐⭐⭐⭐

    “The care was exceptional — every question was answered, every need was met. I’m now on the path to full recovery and filled with hope.”

    Okie Fanny, Cervical Cancer, Cameroon ⭐⭐⭐⭐⭐

    Your information is safe and confidential.